Skip to main navigation Skip to search Skip to main content

Investigating the ideal wear time for transdermal bilayer microneedle array patches (MAP) for delivering HIV therapeutic islatravir.

Research output: Contribution to conferencePosterpeer-review

Original languageEnglish
Publication statusPublished (in print/issue) - 2025

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Cite this